IL9RP4

Across TCGA pan-cancer cohorts, IL9RP4 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated IL9RP4 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher IL9RP4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IL9RP4 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

COAD, LIHC, and THYM are the cancer types where IL9RP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.192	0.558	.001	84	view →
LIHC	OS	Tertile	All	0.324	0.789	<.001	45	view →
THYM	DFS	Tertile	III,IV	0.214	1.000	.008	33	view →
ACC	OS	Tertile	III,IV	0.345	0.766	<.001	27	view →
LUSC	DFS	Tertile	All	0.779	0.443	.014	21	view →
DLBC	OS	Tertile	IV	0.342	0.930	.045	18	view →
THCA	DFS	Tertile	III,IV	0.415	0.704	.014	18	view →
KIRC	DFS	Tertile	III,IV	0.638	0.764	.035	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
LGG	OS	Tertile	All	0.171	0.480	.001	9	view →
TGCT	OS	Tertile	All	0.879	0.981	.047	6	view →
HNSC	DFS	Tertile	II,III,IV	0.579	0.699	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

IL9RP4–COAD (OS)

Open the COAD breakdown →